Zydus Lifesciences Ltd. on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in Gujarat.
The US Food and Drug Administration inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.
The inspection closed with ten observations, it added.
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner, Zydus Lifesciences said.
ADVERTISEMENT
Shares of the company were trading 2.79% down at Rs 932.80 apiece on the BSE.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
More Than 200 Investors Tricked By Scammers Posing As Prime Securities’ Unit — Modus Operandi Explained
Aug 23, 2025
Hindustan Zinc To Establish India's First Zinc Tailing Processing Unit, Share Price Rises
Aug 19, 2025
Indian Company's Cookware Products Likely To Cause Lead Poisoning, USFDA Warns
Aug 18, 2025
Oracle Layoffs: Tech Giant Cuts Jobs in Cloud Infrastructure Unit Amid AI Spending
Aug 13, 2025
POPULAR
1
'Incompetent Management With Fat Salaries...': Vijay Kedia Reacts To Investors' Viral Rant At AGM
2
Empowering India's Dual-Income Families For Financial Freedom: New Era Of Resilience
3
Future Looks Extremely Bright, India Aims Manned Mission To Moon By 2040: Shubhanshu Shukla
4
Delhi HC Sets Aside CIC Order On PM Modi's DU Degree Disclosure
5